Tgf.beta. rii receptor nucleic sequence, coded peptide, and uses
CA 2299678 A1 · Owner: Acres, Bruce · Inventors: Acres, Bruce
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns a peptide comprising or consisting of a first peptide sequence of not more than 20 consecutive amino acids defined in a second peptide sequence coded by all or part of SEQ ID NO: 42 and different from SEQ ID NO: 1 said peptide being capable of being fixed on at least a class I major histocompatibility complex (MHC I) glycoprotein. The invention also concerns all nucleic sequence coding for such a peptide and the uses thereof in a vector a host cell and in a pharmaceutical composition for diagnosing preventing or treating in particular gastric or colon cancers.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 8, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 8, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 8, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.